Quad Technologies Company Profile

13:23 EDT 22nd March 2018 | BioPortfolio

Established in 2013, Quad Technologies is a developer of novel cell separation technology with significant advantages over conventional approaches for the binding and releasing of rare cells. With a product driven business model, the company is committed to answering the needs of researchers working in cell separation applications –

News Articles [202 Associated News Articles listed on BioPortfolio]

Quad Technologies Expands After New HQ, Lab Move

The company says the move "changes the game" for Quad Technologies and its customers

Quad wins patent for alternative to magnetic beads in CAR T separation

Cell therapy makers need scalable technologies that do not rely on magnetic beads for separation or culture, says Quad Technologies.

Sartorius inks deal for Quad's T cell activation tech

Quad Technologies has teamed with Sartorius Stedim Biotech to expand the reach of its T-cell activation reagent for cell and gene therapy production.

Quad Technologies Opens New HQ to Support cGMP Manufacturing of QuickGel™ for T-Cell Activation

Quad Technologies, a leader in cell and gene therapy bioprocessing reagents, announced today that it has opened a new, larger headquarters and laboratory that allows the co...

Quad Technologies Patents Novel T-Cell Activation Reagent for Car-T Cell Manufacturing

Quad Technologies, a leader in cell and gene therapy bioprocessing reagents, announced today the U.S. Patent and Trademark Office has awarded the company a new U.S. Patent,...

Quad Technologies Partners With Sartorius Stedim Biotech On CD3/CD28 T Cell Activation Product

Quad Technologies, a visionary innovator in cell and gene therapy bioprocessing, today announced a collaboration with Sartorius Stedim Biotech, a leading provider of cuttin...

Opioids on the Quad

For one student, it began with a painkiller snorted in a friend’s basement. For another, it was speed, pushed by the boy in the next locker.

Quad-strain meningococcal vaccine to be added to Australia’s NIP

To help protect our youngest Australians from the devastating consequences of meningococcal, the Australian…

PubMed Articles [349 Associated PubMed Articles listed on BioPortfolio]

Health technology assessments conducted in health care facilities: A strategic practice? Findings from a content analysis of HTA reports.

In this paper, we test the hypothesis that health technology assessment units located in hospitals tend to be more optimistic toward technologies that are currently in use in their organization than t...

Three-dimensional Technologies in Orthopedics.

New 3-dimensional digital technologies are revolutionizing orthopedic clinical practice, allowing structures of any complexity to be manufactured in just hours. Such technologies can make surgery for ...

Tropism of engineered and evolved recombinant AAV serotypes in the rd1 mouse and ex vivo primate retina.

There is much debate on the adeno-associated virus (AAV) serotype that best targets specific retinal cell types and the route of surgical delivery-intravitreal or subretinal. This study compared three...

Selective Inhibition of Nuclear Export With Oral Selinexor for Treatment of Relapsed or Refractory Multiple Myeloma.

Purpose Selinexor, a first-in-class, oral, selective exportin 1 (XPO1) inhibitor, induces apoptosis in cancer cells through nuclear retention of tumor suppressor proteins and the glucocorticoid recept...

A brief review of single-cell transcriptomic technologies.

In recent years, there has been an effort to develop new technologies for measuring gene expression and sequence information from thousands of individual cells. Large data sets that were obtained usin...

Clinical Trials [367 Associated Clinical Trials listed on BioPortfolio]

Study of the Safety and Efficacy of Elvitegravir/Emtricitabine/Tenofovir Disoproxil Fumarate/GS-9350 (QUAD) Versus Atripla(R) in HIV Infected, Antiretroviral Treatment-Naive Adults

The objective of this study is to evaluate the safety and efficacy of a single tablet regimen containing fixed doses of elvitegravir/emtricitabine/tenofovir disoproxil fumarate/GS 9350 ver...

Efficacy Study of the Octapolar Lead in Patients With Failed Back Surgery Syndrome (FBSS) With Chronic Pain

Spinal cord stimulation (SCS) has been used for over 40 years to treat neuropathic pain. Various clinical studies have shown a beneficial effect of SCS on pain in patients with Failed Back...

Application of Monitoring and Intervention Technologies in Suboptimal Health Status

The purpose of this study is to use monitoring and intervention technologies in suboptimal health status in a general population in China and evaluate the effectiveness of these technologi...

Wheeze Detection in Adults During Dynamic Bronchial Situations Measured by PulmoTrack® 2010 With WIM-PC™ Technologies Recording

The PulmoTrack® 2010 with WIM-PC™ Technologies device, indicated for acoustic pulmonary function measurement that quantifies the presence of wheezing. This study was designed in order t...

Testing Latest Version of NidekRS3000Adv

The investigators would like to know if different imaging devices can improve the quality of images and visualization of imaged tissues. Also, the investigators would like to find out whet...

Companies [1254 Associated Companies listed on BioPortfolio]

Quad Technologies

Established in 2013, Quad Technologies is a developer of novel cell separation technology with significant advantages over conventional approaches for the binding and releasing of...

Quad-C Management

Founded in 1989 and headquartered in Charlottesville, Virginia, Quad-C is a middle market private equity firm focused on investing in well-established business services, consumer,...

Quad/Graphics, Inc.

Quad/Graphics (NYSE: QUAD) is a global marketing services provider that helps brand owners market their products, services and content more efficiently and effectively. To do this...


At the forefront of innovation for 45 years, Quad/Graphics (NYSE: QUAD) is a leading print and marketing services provider focused on helping brand owners market their products, s...

Quad-C Management, Inc.

More Information about "Quad Technologies" on BioPortfolio

We have published hundreds of Quad Technologies news stories on BioPortfolio along with dozens of Quad Technologies Clinical Trials and PubMed Articles about Quad Technologies for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Quad Technologies Companies in our database. You can also find out about relevant Quad Technologies Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record